“Don’t take Tylenol,” Trump instructed pregnant women around a dozen times during a White House news conference. He also ...

Families appealing the dismissal of their lawsuits alleging that Kenvue's Tylenol or generic versions of the pain-relief ...

Kenvue shares rose 6% in premarket trading on Tuesday, set to rebound from a record low hit in the previous session as U.S.

Kenvue's profitability, with gross margins above 58% and EBITDA margins over 23%, provides resilience against legal and ...

Shares may be rising because investors expected the White House to announce stricter regulations on the medication, Citi ...

President Donald Trump created a potentially existential crisis for Tylenol maker Kenvue Inc. with just three words about the ...

Trump announced that Tylenol could cause autism on Sept. 22, 2025, during a press conference at the White House. A Kenvue Inc ...

Tylenol maker Kenvue is reportedly preparing for a glut of lawsuits after President Donald Trump made a baseless warning that ...

Analysts saw no new scientific evidence from the White House to support President Donald Trump linking Tylenol to autism.

Independent, sound science clearly shows that taking acetaminophen does not cause autism,” a Kenvue spokesperson told ...

Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could ...

Economists saw “limited” risk to the pharmaceutical firm’s stock, despite some expected impact on Tylenol consumption.